一种17β基类固醇脱酶10型 (17β-HSD10) 抑制剂的合成和生物特征
Louise F Dow1, Rasangi Pathirage1, Helen E Erickson1
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center Omaha Nebraska 68198 USA paul.trippier@unmc.edu.
RSC medicinal chemistry
|December 2, 2024
概括
研究人员合成了一种向17β-HSD10的化合物,这种酶与阿尔茨海默病 (AD) 有关. 虽然该化合物对癌细胞具有毒性,但其中间体在保护神经元免受β粉样蛋白的影响方面表现出潜力,为AD药物发现提供了新的途径.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 有机合成 有机合成
背景情况:
- 阿尔茨海默病 (AD) 影响全球超过5500万,有限的治疗影响疾病的进展.
- 氧类固醇17-β脱酶10型 (17β-HSD10) 是一种线粒体酶,通过粉样β相互作用与AD病变发生有关.
- 迫切需要新的蛋白质标和小分子治疗方法来治疗AD.
研究的目的:
- 报告第一个合成访问17β-HSD10抑制剂BCC0100281.1.
- 探索BCC0100281及其合成中间体对神经退行性疾病和癌症的治疗潜力.
主要方法:
- 融合合成途径使用简单的异环结构积木.
- 基于细胞的测试来评估化合物毒性和神经保护作用.
- 对新型治疗支架的合成中间体进行选.
主要成果:
- 成功合成了17β-HSD10抑制剂BCC0100281.1. 这是一种成功的合成.
- BCC0100281对神经母细胞瘤细胞表现出毒性,这表明癌症药物发现的潜力.
- 来自合成中间体的新型支架在拯救粉样β诱导的细胞毒性方面表现出有效性.
结论:
- 合成为潜在的阿尔茨海默病和癌症治疗候选人提供了一条路径.
- 药物化学和有机合成努力从17β-HSD10抑制剂中间体中产生了有希望的神经保护性支架.
- 这项工作突出了合成化学在优化药物发现成功的实用性.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
Structure-Activity Relationships and Drug Design
554
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
554
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
9.8K
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
9.8K
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K


